← Leaderboards
Joseph Edward Ippolito
Washington University
$3,581,780
Attributed
$6,007,827
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,007,827 · 7
By mechanism
R01$3,994,569 · 2
R21$776,150 · 2
R00$746,642 · 1
T32$339,127 · 1
K99$151,339 · 1
Top collaborators
- Eric H Kim7 shared
- Michael Hiroshi Johnson2 shared
- Hongyu An1 shared
- Richard Leo Wahl1 shared
- Pamela K Woodard1 shared
Most similar at Washington University
Same institution · by research overlap
- Sheng-Kwei Song$14,973,079
- Yong Wang$8,889,709
- Randall J Bateman$192,965,895
- Dorothy Anne Cross$5,584,847
- Tammie Lee Smith Benzinger$27,265,928
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorMagnetic Resonance ImagingMalignant NeoplasmsImageProstateCancer PatientMetabolicCancer DiagnosisTrainingMetabolismIn VivoPatient StratificationImaging ModalityInsightDiffusionBiochemicalTissuesAdultExperimental StudyDiagnosisFemaleGonadal Steroid HormonesBiological MarkersAstrocytes
Grant awards (15)
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches$592,905
R01 · FY2025 · CA · contact PI
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$512,247
R01 · FY2025 · CA · contact PI
New models for interrogating the impact of sex chromosomes and sex hormones on glioblastoma$399,829
R21 · FY2025 · CA · contact PI
Training OPportunites in Translational Imaging Education and Research (TOP-TIER)$339,127
T32 · FY2025 · EB
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches$592,860
R01 · FY2024 · CA · contact PI
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$534,257
R01 · FY2024 · CA · contact PI
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches$637,936
R01 · FY2023 · CA · contact PI
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$581,203
R01 · FY2023 · CA
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer$543,161
R01 · FY2022 · CA
CHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISM$248,998
R00 · FY2020 · CA · contact PI
Understanding Sex Disparities in Gliomas Through Sex Differences in Mitochondrial Activity$205,538
R21 · FY2020 · CA · contact PI
CHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISM$248,644
R00 · FY2019 · CA · contact PI
Understanding Sex Disparities in Gliomas Through Sex Differences in Mitochondrial Activity$170,783
R21 · FY2019 · CA · contact PI
CHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISM$249,000
R00 · FY2018 · CA · contact PI
CHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISM$151,339
K99 · FY2017 · CA · contact PI